» Articles » PMID: 15682455

Survival Versus Neglect: Redefining Thymocyte Subsets Based on Expression of NKG2D Ligand(s) and MHC Class I

Overview
Journal Eur J Immunol
Date 2005 Feb 1
PMID 15682455
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

BALB/c thymocytes can be divided into three distinct subsets according to the expression of a ligand for the NK activation receptor NKG2D (NKG2D-L) and the expression of MHC class I (MHC-I). The first subset (MHC-Imid/NKG2D-Lhigh or "N+") is predominately CD4+CD8+ double positive (DP), comprises approximately 35% of thymocytes in a 6-8-week-old adult and contains uncommitted cells that have neither undergone selection nor are committed to death by neglect. The second subset (MHC-Ilow/NKG2D-Llow or "M-"), also mostly DP cells, comprises approximately 50% of thymocytes and consists of cells committed to death by apoptosis, likely due to neglect. By contrast, the third subset (MHC-Ihigh/NKG2D-Llow or "M+") is largely single positive (SP), represents approximately 15% of thymocytes and mostly contains more mature cells that have undergone successful positive selection. The major advantage of the analysis is that it splits DP cells into two subpopulations, one committed to death by apoptosis and the other subjected to selection. The analysis also suggests that NKG2D-L may play a role in thymocyte development.

Citing Articles

More than Decoration: Roles for Natural Killer Group 2 Member D Ligand Expression by Immune Cells.

Trembath A, Markiewicz M Front Immunol. 2018; 9:231.

PMID: 29483917 PMC: 5816059. DOI: 10.3389/fimmu.2018.00231.


NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses.

Zingoni A, Ardolino M, Santoni A, Cerboni C Front Immunol. 2013; 3:408.

PMID: 23316196 PMC: 3540764. DOI: 10.3389/fimmu.2012.00408.


Chemotherapy-induced genotoxic stress promotes sensitivity to natural killer cell cytotoxicity by enabling missing-self recognition.

Fine J, Chen P, Mesci A, Allan D, Gasser S, Raulet D Cancer Res. 2010; 70(18):7102-13.

PMID: 20823164 PMC: 3108335. DOI: 10.1158/0008-5472.CAN-10-1316.


Beyond Stressed Self: Evidence for NKG2D Ligand Expression on Healthy Cells.

Eagle R, Jafferji I, Barrow A Curr Immunol Rev. 2009; 5(1):22-34.

PMID: 19626129 PMC: 2713595. DOI: 10.2174/157339509787314369.


Regulation of ligands for the activating receptor NKG2D.

Mistry A, OCallaghan C Immunology. 2007; 121(4):439-47.

PMID: 17614877 PMC: 2265965. DOI: 10.1111/j.1365-2567.2007.02652.x.